CYTORI THERAPEUTICS INC

Inactive Instrument

Analyst Reco. Cytori Therapeutics Inc Deutsche Boerse AG

Equities

US23283K1051

End-of-day quote Deutsche Boerse AG Other stock markets
- ^EUR	-

Jun. 07	Plus Therapeutics, Inc. Receives the Resignation of Dr. Norman Lafrance, Its Chief Medical Officer, Effective June 12, 2024	CI
Jun. 07	Plus Therapeutics to Receive $3.3 Million Advance Payment From CPRIT For Radiotherapeutic Development Program	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Plus Therapeutics to $8 From $3.50, Maintains Buy Rating	23-06-30	MT
Maxim Adjusts Price Target on Plus Therapeutics to $12 From $30, Maintains Buy Rating	23-05-03	MT
JonesTrading Starts Plus Therapeutics at Buy With $5 Price Target	22-10-07	MT
HC Wainwright Adjusts Plus Therapeutics' Price Target to $3.50 from $7, Keeps Buy Rating	22-07-22	MT
PLUS THERAPEUTICS : HC Wainwright Starts Plus Therapeutics at Buy With $7 Price Target	21-02-11	MT
PLUS THERAPEUTICS : Ladenburg Thalmann Starts Plus Therapeutics at Buy With $8 Price Target	21-01-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Secure my Investments

fermer